33
Participants
Start Date
December 6, 2023
Primary Completion Date
April 1, 2025
Study Completion Date
May 6, 2025
LY3972406
Administered orally
Placebo
Administered orally
DermDox Centers for Dermatology, Camp Hill
Accellacare - Winston-Salem, Winston-Salem
Conquest Research, Winter Park
Driven Research, Coral Gables
Remington-Davis, Inc, Columbus
Center for Clinical Studies, Houston
Austin Institute for Clinical Research, Houston
Dermatology Research Associates, Los Angeles
Clinical Science Institute, Santa Monica
Psoriasis Treatment Center of Central New Jersey, East Windsor
Schweiger Dermatology Group, Hackensack
Metropolitan Dermatology - Clark, Kenilworth
Eli Lilly and Company
INDUSTRY